Treatment of Graves' ophthalmopathy with new immunosuppressive agents.
Utech
C
C
Deutsche Klinik für Diagnostik, Wiesbaden, FRG.
Wulle
K G
KG
Panitz
N
N
Kiefer
H
H
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001388:Aziridines / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006111:Graves Disease / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007429:Intraocular Pressure / Q000187:drug effects; D014065:Tonometry, Ocular; D014787:Vision Tests
D000276:Adjuvants, Immunologic; D001388:Aziridines; D003524:Cyclosporins; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; C035520:ciamexon